LPL Financial
PDLI

LPL Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

LPL Financial’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-41,864
Closed -$123K – 3352
2018
Q1 		$123K Buy
41,864
+3,695
+10% +$10.1K ﹤0.01% 3053
2017
Q4 		$105K Sell
38,169
-55,733
-59% -$171K ﹤0.01% 2928
2017
Q3 		$318K Sell
93,902
-2,205
-2% -$6.13K ﹤0.01% 2316
2017
Q2 		$237K Sell
96,107
-2,427
-2% -$5.58K ﹤0.01% 2461
2017
Q1 		$227K Sell
98,534
-2,653
-3% -$5.87K ﹤0.01% 2403
2016
Q4 		$226K Sell
101,187
-46,851
-32% -$131K ﹤0.01% 2390
2016
Q3 		$484K Sell
148,038
-14,377
-9% -$45.6K ﹤0.01% 1749
2016
Q2 		$516K Sell
162,415
-146,865
-47% -$490K ﹤0.01% 1641
2016
Q1 		$1.02M Buy
309,280
+79,967
+35% +$249K ﹤0.01% 1658
2015
Q4 		$793K Buy
229,313
+78,293
+52% +$328K ﹤0.01% 1864
2015
Q3 		$790K Buy
151,020
+12,467
+9% +$71.4K ﹤0.01% 1420
2015
Q2 		$856K Buy
138,553
+10,312
+8% +$69.1K ﹤0.01% 1488
2015
Q1 		$919K Buy
128,241
+61,175
+91% +$443K ﹤0.01% 1414
2014
Q4 		$517K Sell
67,066
-8,726
-12% -$69.1K ﹤0.01% 1747
2014
Q3 		$569K Sell
75,792
-64,352
-46% -$597K ﹤0.01% 1687
2014
Q2 		$1.36M Buy
140,144
+32
+0% +$285 0.01% 1125
2014
Q1 		$1.16M Sell
140,112
-1,881
-1% -$16.1K 0.01% 1166
2013
Q4 		$1.2M Buy
141,993
+26,288
+23% +$222K 0.01% 1120
2013
Q3 		$929K Buy
115,705
+31,897
+38% +$256K 0.01% 1228
2013
Q2 		$647K Buy
+83,808
New +$653K ﹤0.01% 1390

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

LPL Financial's PDLI Position: Q2 2018 in Review

LPL Financial sold out of PDL BioPharma, Inc. (PDLI) in Q2 2018, closing a stake of 41,864 shares — an estimated $123K sold.

LPL Financial first reported a position in PDLI in Q2 2013 and held it in 20 quarters. The position peaked at $1.36M in Q2 2014. 163 funds tracked by Wall St. Rank hold PDLI as of Q2 2018.

  • LPL Financial reported no remaining PDL BioPharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • LPL Financial sold 41,864 PDL BioPharma, Inc. shares in Q2 2018, an estimated $123K.
  • LPL Financial first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 20 quarters.
  • LPL Financial's PDL BioPharma, Inc. position peaked at $1.36M in Q2 2014.
  • 163 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2018.

Based on LPL Financial's 13F filing for Q2 2018, filed 14 Aug 2018.